Table 1.

Association studies of MIR137 rs1625579 polymorphism with risk of schizophrenia.

Source	Population	Schizophrenia patients				Healthy controls				P-value
		N	Genotype frequencies (%)			N	Genotype frequencies (%)
			T/T	G/T	G/G		T/T	G/T	G/G
Sun et al. (14)	China	589	86.9	12.2	0.9	622	86.8	12.7	0.5	p > 0.05
Kuswanto et al. (8)	Singapore	84	89.2	10.8		63	88.9	11.1		p > 0.05
Yuan et al. (15)	China	506	87.9	11.7	0.4	522	89.6	10.4	0	p > 0.05
Wang et al. (16)	China	300	89.7	10.3	0	300	88.3	11.7	0	p > 0.05
Guan et al. (10)	China	1429	77.7	20.8	1.5	1570	74	23.6	2.4	p = 0.023
Van Erp et al. (11)	US	48	81.25	18.75	0	63	73.02	23.81	3.17	p > 0.05
Hommers et al. (5)	GWAS, 2014	Caucasians n (patients) = 33.332 n (controls) = 27.888								p < 0.05
	GWAS, 2013	Sweden samples: n (patients) = 5.001, n (controls) = 6.243; Repeated study 1 (Caucasians): n (patients) = 8.832, n (controls) = 12.067; Repeated study 2 (Caucasians): n (patients) = 7.413, n (controls) = 19.762								p < 0.05
	GWAS, 2011	Caucasians n (patients) = 9.394 n (controls) = 12.462 Repeated study n (patients) = 8.432 n (controls) = 21.397								p < 0.05

GWAS, genome wide association study. Bold values indicate the mean statistical significance or % value.